Infection with influenza virus is responsible for a great deal of morbidity and mortality worldwide. In non-pandemic years, 10-20% of the population in the US is infected with influenza virus. In any given year, more than 120,000 persons are hospitalized and 36,000 Americans die from influenza and influenza-related complications. In the case of an influenza pandemic, each of these measures of morbidity and mortality would greatly increase. With the expectation of a pandemic influenza outbreak in the near future, it is extremely important to determine if obese individuals are at an increased risk for vaccine failure. Several published studies showing diminished antibody response to vaccination with hepatitis B in obese adults and diminished antibody response to tetanus vaccination in obese children and our own preliminary data in obese adults, suggests that obese individuals are at increased risk for higher rates of influenza vaccine failure. This proposal is designed to determine if the obese population has a diminished response to influenza vaccination. The elderly population has a higher rate of vaccine failure compared to a younger population, and many of the immune dysfunctions seen in the elderly (reduced antibody responses, impaired T cell reactivity) have also been found in the obese. This suggests that, similar to an aging population, an obese population may not respond adequately to flu vaccination. Our study will answer the following questions relating to vaccine responsiveness in an obese population: Does influenza vaccination protect an obese population from influenza infection to the same degree as a lean population? Is the response to influenza vaccine, measured by production of antibody as well as the ability of T cells to respond to influenza antigen, impaired in an obese population? Can levels and/or characteristics of the chronic inflammatory stress proteins found in obese individuals differentiate between those who respond to influenza vaccination and those that don't? If we determine that obesity is associated with an impaired immune response to influenza vaccination and decreased protection against influenza infection, this would suggest that we need to re-evaluate our vaccination program, not only for influenza, but perhaps for other pathogens as well, in an increasingly obese US population.

Public Health Relevance

Rates of obesity are increasing rapidly worldwide resulting in major impacts on health status and disease prevention. Additionally, the threat of pandemic influenza has grown in recent years with the discovery of new strains and an increasingly susceptible population. Determination of influenza vaccination effectiveness in the obese population will provide an invaluable resource in determining the best way to prevent the initiation and spread of any forthcoming influenza pandemic and provide new insights into the effect of obesity on function of the immune system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI078090-03
Application #
8002059
Study Section
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Program Officer
Kim, Sonnie
Project Start
2008-12-01
Project End
2012-03-31
Budget Start
2010-12-01
Budget End
2012-03-31
Support Year
3
Fiscal Year
2011
Total Cost
$501,393
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Nutrition
Type
Schools of Public Health
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Kosaraju, Rasagna; Guesdon, William; Crouch, Miranda J et al. (2017) B Cell Activity Is Impaired in Human and Mouse Obesity and Is Responsive to an Essential Fatty Acid upon Murine Influenza Infection. J Immunol 198:4738-4752
Neidich, S D; Green, W D; Rebeles, J et al. (2017) Increased risk of influenza among vaccinated adults who are obese. Int J Obes (Lond) 41:1324-1330
Green, William D; Beck, Melinda A (2017) Obesity altered T cell metabolism and the response to infection. Curr Opin Immunol 46:1-7
Sheridan, Patricia A; Paich, Heather A; Handy, Jean et al. (2015) The antibody response to influenza vaccination is not impaired in type 2 diabetics. Vaccine 33:3306-13
Shaikh, S R; Haas, K M; Beck, M A et al. (2015) The effects of diet-induced obesity on B cell function. Clin Exp Immunol 179:90-9
Karlsson, Erik A; Ip, Hon S; Hall, Jeffrey S et al. (2014) Respiratory transmission of an avian H3N8 influenza virus isolated from a harbour seal. Nat Commun 5:4791
Meliopoulos, Victoria A; Kayali, Ghazi; Burnham, Andrew et al. (2014) Detection of antibodies against Turkey astrovirus in humans. PLoS One 9:e96934
Paich, Heather A; Sheridan, Patricia A; Handy, Jean et al. (2013) Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring) 21:2377-86
Sheridan, P A; Paich, H A; Handy, J et al. (2012) Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 36:1072-7
Meydani, Simin Nikbin; Beck, Melinda A (2012) The relationship of host nutritional status to immune function. Mol Aspects Med 33:1

Showing the most recent 10 out of 13 publications